
1823: Secretary of Egg
FDA Policy Changes and German Excess Mortality Study
The FDA, under Dr. Vinay Prasad, is reportedly moving away from "immunobridging" studies for vaccine approvals, requiring more rigorous outcome data. This change is linked to revelations of pediatric deaths following COVID-19 vaccinations. Simultaneously, a new actuarial study from Germany published on NIH.gov shows a strong correlation between high vaccination rates and excess mortality in the third year of the pandemic, a topic largely ignored by mainstream media.








